Gladstone Institutional Advisory’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Gladstone Institutional Advisory's AZN Position: Q3 2026 in Review
Gladstone Institutional Advisory reduced its AstraZeneca (AZN) stake by 12% in Q3 2026, selling an estimated $33.3K and leaving 1,483 shares worth $240K. The position accounts for 0.01% of the portfolio, ranked #886.
Gladstone Institutional Advisory first reported a position in AZN in Q3 2020 and has held it in 9 quarters since. The position peaked at $360K in Q3 2020. 1,446 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Gladstone Institutional Advisory held 1,483 shares of AstraZeneca worth $240K as of Q3 2026.
- Gladstone Institutional Advisory sold 200 AstraZeneca shares in Q3 2026, an estimated $33.3K.
- AstraZeneca made up 0.01% of Gladstone Institutional Advisory's portfolio in Q3 2026, its #886 holding.
- Gladstone Institutional Advisory first reported a position in AstraZeneca in Q3 2020 and has held it in 9 quarters since.
- Gladstone Institutional Advisory's AstraZeneca position peaked at $360K in Q3 2020.
- 1,446 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Gladstone Institutional Advisory's 13F filing for Q3 2026, filed 13 Nov 2026.